LysoPC(16:0/0:0)
|
Basic information |
| Metabolite name | LysoPC(16:0/0:0) |
 | HMDB0010382 |
 |
C04230 |
 |
460602 |
| Synonyms | 1-Palmitoyl-sn-glycero-3-phosphocholine; |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | LysoPC(16:0/0:0) |
| HMDB0010382 |
|
C04230 |
|
460602 |
| Synonyms | 1-Palmitoyl-sn-glycero-3-phosphocholine; |
| No. of studies | 4 |
|
Relationship between LysoPC(16:0/0:0) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M572 | Type1 | major antenatal depression group vs. control group | Plasma | Human | Up |
| Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |